Q4 2024 Management View CEO Ashish Chand highlighted that Belden exceeded its guidance for Q4 2024, achieving $666 million in revenue and an EPS of $1.92. Revenue grew 21% year-over-year, while ...
Yum Brands Q4 Worldwide Systems Sales Ex-Forex Up 8%; Opened 1,804 Gross Units in Q4… David Gibbs, CEO, said “2024 was marked with exceptional core operating profit growth given the complex consumer ...
Eli Lilly's Q4 revenue surged 45% to $13.53 billion, fueled by Mounjaro and Zepbound. 2025 guidance forecasts up to $61 billion in sales, driven by new drug launches.
ConocoPhillips (NYSE: COP) reported Q4 results, with $14.74B revenue and $1.98 EPS, surpassing expectations. Company also announced dividends and production targets for 2025.
Q4 2024 Management View CEO Eric Ashleman highlighted strong performance in Q4 2024, with notable achievements in the Health & Science Technologies (HST) segment, including impactful projects in ...
Some results have been hidden because they may be inaccessible to you